Literature DB >> 10330940

Proximal bile duct stricture disguised as malignant neoplasm.

A Nakayama1, H Imamura, R Shimada, S Miyagawa, M Makuuchi, S Kawasaki.   

Abstract

BACKGROUND: Discrimination of malignant proximal bile duct (PBD) stricture from a benign lesion is difficult with nonsurgical methods; indeed, 8% to 13% of PBD strictures prove to be benign after histologic examination of the surgically resected specimen.
METHODS: In a 7-year period 178 patients with PBD stricture were admitted, and 99 of them underwent radical resection for presumably malignant lesions. In 14 of these patients the stenotic lesions were proved to be benign by postoperative histologic assessment. We reviewed these patients retrospectively by collecting data from their charts.
RESULTS: Preoperative radiologic findings including cholangiography and angiography were compatible with malignancy in all 14 patients. Preoperative histologic studies suggested malignancy in 2 of 8 examined. Findings at laparotomy could not allow differentiation between malignant and benign lesions in any of the patients and strongly suggested malignancy in 3. Histologic examination of the resected specimens revealed extensive fibrosis with inflammatory cellular infiltration in all patients. There was 1 episode of significant morbidity postoperatively (transient cholangitis) but no mortality.
CONCLUSION: Benign PBD strictures, although rare, are usually indistinguishable from malignant PBD strictures by preoperative or perioperative investigation. Given the minimal morbidity, all PBD strictures should be presumed malignant and managed accordingly, even at the risk of overtreating some benign cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330940

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma.

Authors:  Jaap Jacob Kloek; Otto Marinus van Delden; Deha Erdogan; Fibo Jan ten Kate; Erik Anthoni Rauws; Olivier-Robert Busch; Dirk Joan Gouma; Thomas Mathijs van Gulik
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 2.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

3.  Malignant masquerade at the hepatic hilum.

Authors:  Disha Sood; Rahul Kakodkar; Vinay Kumaran; Ravi Mohanka; Samiran Nundy; Arvinder Singh Soin
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

4.  EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence.

Authors:  Saori Onda; Takeshi Ogura; Yoshitaka Kurisu; Daisuke Masuda; Tatsushi Sano; Wataru Takagi; Shinya Fukunishi; Kazuhide Higuchi
Journal:  Therap Adv Gastroenterol       Date:  2016-02-11       Impact factor: 4.409

5.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

6.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

7.  Eosinophilic cholangitis: a case of 'malignant masquerade'.

Authors:  M S Rodgers; J P Allen; J B Koea; J L McCall
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

Review 8.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

9.  Radiological diagnosis and staging of hilar cholangiocarcinoma.

Authors:  Carlos Valls; Sandra Ruiz; Laura Martinez; David Leiva
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

10.  Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?

Authors:  E Buc; M Lesurtel; J Belghiti
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.